Admin1337 Ventures has announced the Top 10 finalists for the Alpha Startups™ INNO4HER 2026 programme, highlighting a growing shift in women’s health innovation towards deeper clinical and systemic solutions.
Selected from a competitive pool of applicants since the accelerator began in January, the finalists represent a diverse mix of startups from Malaysia, Singapore, Hong Kong, the Philippines and Poland. The cohort reflects increasing global urgency to address longstanding gaps in women’s healthcare, particularly in areas such as fertility, maternal care and hormonal health.
“The next wave of FemTech is deeper, more structural, and increasingly clinical,” said Bikesh Lakhmichand, CEO and Founding Partner at 1337 Ventures. “This year’s INNO4HER Top 10 startups are tackling some of the most complex and historically underfunded areas of women’s health, turning overlooked data, biology, and care gaps into meaningful innovation. It is encouraging to see founders pushing the boundaries of what FemTech can achieve for the future of global healthcare.”
Broadening scope of women’s health innovation
The 2026 cohort signals a notable evolution in FemTech, moving beyond consumer-focused tracking applications towards more comprehensive and clinically relevant solutions. Among the selected startups are Amiya and Eve Fertility, which aim to improve access and emotional support in fertility care, as well as Bosom, which focuses on integrated maternal healthcare from pregnancy through postpartum.
Other startups such as FemFast and Supple AI are leveraging artificial intelligence to provide personalised guidance on hormonal health and perimenopause, while Hati Health is addressing polycystic ovary syndrome (PCOS) through holistic care models. Meanwhile, MenSC Labs is exploring the use of menstrual blood for stem cell research, highlighting emerging scientific frontiers in the sector.
Malaysia’s Siikat stands out with its focus on wellness infrastructure, introducing headspa suites designed for nervous system regulation within gym environments. Navo Health and Shinaraa round out the list, offering innovations in fetal monitoring and sustainable functional womenswear respectively.
Demo Day to spotlight regional investment interest
The finalists are currently undergoing the final phase of a hybrid acceleration programme, receiving mentorship and guidance from industry players including Epic Angels and Microsoft’s startup ecosystem initiatives.
The programme will culminate in the INNO4HER Demo Day on March 31 at Microsoft Malaysia, where the startups will pitch to regional venture capitalists, angel investors and healthcare leaders.
The judging panel includes Hester Spiegel-vdSteenhoven of Epic Angels, Smita Roy from Microsoft, Amelia Ong of OSK Ventures International, and Ain Azizah Arifin of Bubbles O2.
As investor appetite for FemTech continues to grow, the INNO4HER platform underscores Southeast Asia’s increasing role as a hub for healthcare innovation, while also reflecting the broader global push to close critical gaps in women’s health services.
Jimmy Tan
Add comment